These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

621 related articles for article (PubMed ID: 9486667)

  • 1. Molecular determinants of dofetilide block of HERG K+ channels.
    Ficker E; Jarolimek W; Kiehn J; Baumann A; Brown AM
    Circ Res; 1998 Feb; 82(3):386-95. PubMed ID: 9486667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular determinants of inactivation and dofetilide block in ether a-go-go (EAG) channels and EAG-related K(+) channels.
    Ficker E; Jarolimek W; Brown AM
    Mol Pharmacol; 2001 Dec; 60(6):1343-8. PubMed ID: 11723241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular physiology and pharmacology of HERG. Single-channel currents and block by dofetilide.
    Kiehn J; Lacerda AE; Wible B; Brown AM
    Circulation; 1996 Nov; 94(10):2572-9. PubMed ID: 8921803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of block and identification of the verapamil binding domain to HERG potassium channels.
    Zhang S; Zhou Z; Gong Q; Makielski JC; January CT
    Circ Res; 1999 May; 84(9):989-98. PubMed ID: 10325236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High affinity open channel block by dofetilide of HERG expressed in a human cell line.
    Snyders DJ; Chaudhary A
    Mol Pharmacol; 1996 Jun; 49(6):949-55. PubMed ID: 8649354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-affinity blockade of human ether-a-go-go-related gene human cardiac potassium channels by the novel antiarrhythmic drug BRL-32872.
    Thomas D; Wendt-Nordahl G; Röckl K; Ficker E; Brown AM; Kiehn J
    J Pharmacol Exp Ther; 2001 May; 297(2):753-61. PubMed ID: 11303067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dofetilide block involves interactions with open and inactivated states of HERG channels.
    Weerapura M; Hébert TE; Nattel S
    Pflugers Arch; 2002 Feb; 443(4):520-31. PubMed ID: 11907818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Open channel block by KCB-328 [1-(2-amino-4-methanesulfonamidophenoxy)-2-[N-(3,4-dimethoxyphenethyl)-N-methylamino]ethane hydrochloride] of the heterologously expressed human ether-a-go-go-related gene K+ channels.
    Park JB; Choe H; Lee YK; Ha KC; Rhee KS; Ko JK; Joo CU; Chae SW; Kwak YG
    J Pharmacol Exp Ther; 2002 Jul; 302(1):314-9. PubMed ID: 12065732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of the class III antiarrhythmic drug amiodarone on cloned HERG potassium channels.
    Kiehn J; Thomas D; Karle CA; Schöls W; Kübler W
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Mar; 359(3):212-9. PubMed ID: 10208308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acidification alters antiarrhythmic drug blockade of the ether-a-go-go-related Gene (HERG) Channels.
    Dong DL; Li Z; Wang HZ; Du ZM; Song WH; Yang BF
    Basic Clin Pharmacol Toxicol; 2004 May; 94(5):209-12. PubMed ID: 15125690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Class III antiarrhythmic drugs block HERG, a human cardiac delayed rectifier K+ channel. Open-channel block by methanesulfonanilides.
    Spector PS; Curran ME; Keating MT; Sanguinetti MC
    Circ Res; 1996 Mar; 78(3):499-503. PubMed ID: 8593709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [3H]dofetilide binding in SHSY5Y and HEK293 cells expressing a HERG-like K+ channel?
    Finlayson K; Pennington AJ; Kelly JS
    Eur J Pharmacol; 2001 Feb; 412(3):203-12. PubMed ID: 11166283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Open channel block of HERG K(+) channels by vesnarinone.
    Kamiya K; Mitcheson JS; Yasui K; Kodama I; Sanguinetti MC
    Mol Pharmacol; 2001 Aug; 60(2):244-53. PubMed ID: 11455010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific block of cloned Herg channels by clofilium and its tertiary analog LY97241.
    Suessbrich H; Schönherr R; Heinemann SH; Lang F; Busch AE
    FEBS Lett; 1997 Sep; 414(2):435-8. PubMed ID: 9315735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The [3H]dofetilide binding assay is a predictive screening tool for hERG blockade and proarrhythmia: Comparison of intact cell and membrane preparations and effects of altering [K+]o.
    Diaz GJ; Daniell K; Leitza ST; Martin RL; Su Z; McDermott JS; Cox BF; Gintant GA
    J Pharmacol Toxicol Methods; 2004; 50(3):187-99. PubMed ID: 15519905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mechanism for the proarrhythmic effects of cisapride (Propulsid): high affinity blockade of the human cardiac potassium channel HERG.
    Rampe D; Roy ML; Dennis A; Brown AM
    FEBS Lett; 1997 Nov; 417(1):28-32. PubMed ID: 9395068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redox state dependency of HERGS631C channel pharmacology: relation to C-type inactivation.
    Ulens C; Tytgat J
    FEBS Lett; 2000 May; 474(1):111-5. PubMed ID: 10828461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations of the S4-S5 linker alter activation properties of HERG potassium channels expressed in Xenopus oocytes.
    Sanguinetti MC; Xu QP
    J Physiol; 1999 Feb; 514 ( Pt 3)(Pt 3):667-75. PubMed ID: 9882738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Position of aromatic residues in the S6 domain, not inactivation, dictates cisapride sensitivity of HERG and eag potassium channels.
    Chen J; Seebohm G; Sanguinetti MC
    Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12461-6. PubMed ID: 12209010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfer of rapid inactivation and sensitivity to the class III antiarrhythmic drug E-4031 from HERG to M-eag channels.
    Herzberg IM; Trudeau MC; Robertson GA
    J Physiol; 1998 Aug; 511 ( Pt 1)(Pt 1):3-14. PubMed ID: 9679158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.